h
PSC
reg
®
Home
Browse
All cell lines
All hiPSC lines
All hESC lines
Cell line providers
Research projects
Countries
Diseases
Publications
Clinical studies
Info
About hPSCreg
FAQ
Cell Registration
Glossary
Documents & Governance
Fact Sheets
Naming Tool
Publishing your line
Structures
Registration Summary
Certification
Organoids
API
Export Data
SPARQL Guide
Contact
News
Newsletter Subscription
Privacy Policy
Terms of Use
Imprint
Login
Log-in
Sign up
Forgot your password?
This website uses cookies to keep track of login sessions and for internal Matomo Statistics. See our
Privacy Policy
for details.
This website uses cookies,
learn more
x
ASUi001-A
Registration Summary
:
A
P
E
C
160-iPSC
The cell line is
not submitted
yet.
(only basic data is shown)
General
Cell Line
hPSCreg name
ASUi001-A
Cite as:
When citing this cell line, please use the hPSCreg name (see
Naming Tool
) and the corresponding Research Resource ID (RRID).
ASUi001-A (RRID:CVCL_QY80)
Alternative name(s)
160-iPSC
Cell line type
Human induced pluripotent stem cell (hiPSC)
Similar lines
No similar lines found.
Last update
8th December 2017
User feedback
show/hide
Written by
on
Delete
No feedback available yet.
Login
to share your feedback, experiences or results with the research community.
Provider
Generator
Arizona State University (ASU)
External Databases
BioSamples
SAMEA104237464
Cellosaurus
CVCL_QY80
Wikidata
Q54750799
General Information
Publications
Brookhouser N et al. Generation and characterization of human induced pluripotent stem cell (hiPSC) lines from an Alzheimer's disease (ASUi001-A) and non-demented control (ASUi002-A) patient homozygous for the Apolipoprotein e4 (APOE4) risk variant. Stem cell research. 2017 Oct;24:160-163.
Majolo F et al. Important advances in Alzheimer's disease from the use of induced pluripotent stem cells. Journal of biomedical science. 2019 Feb 6;26(1):15.
Raman S et al. Using human induced pluripotent stem cells (hiPSCs) to investigate the mechanisms by which Apolipoprotein E (APOE) contributes to Alzheimer's disease (AD) risk. Neurobiology of disease. 2020 May;138:104788.
Zhao J et al. APOE4 exacerbates synapse loss and neurodegeneration in Alzheimer's disease patient iPSC-derived cerebral organoids. Nature communications. 2020 Nov 2;11(1):5540.
Nilsri N et al. Distinct effects of V617F and exon12-mutated JAK2 expressions on erythropoiesis in a human induced pluripotent stem cell (iPSC)-based model. Scientific reports. 2021 Mar 4;11(1):5255.
Xu W et al. Folate as a potential treatment for lethal ventricular arrhythmias in TANGO2-deficiency disorder. JCI insight. 2024 Jun 10;9(11).
İş Özkan et al. Gliovascular transcriptional perturbations in Alzheimer’s disease reveal molecular mechanisms of blood brain barrier dysfunction. Nature Communications. 2024-06-20.
hIPSC Derivation
General
Login to share your feedback, experiences or results with the research community.